About 3.6 million Medicare beneficiaries could be eligible for Wegovy coverage, study shows
Wegovy was approved by the U.S. health regulator last month for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes. The additional approval would expand Medicare coverage for Wegovy and coverage by other insurers for such adults with heart conditions.
Novo Ozempic Novo Nordisk Kaiser Family Foundation Mariam Sunny Heart Conditions Kaiser Family Foundation
Source: yahoo.com